Neutral impactStocks

Symbiotec Pharmalab IPO subscribed 71x; GMP points to nearly 27% listing gains

CNBC-TV18 3d ago·27 Aug 2026, 12:32 pm

Symbiotec Pharmalab IPO drew strong demand on the final day, with the issue subscribed 71.26 times. QIBs led the bidding at 172.03 times, while the retail portion was subscribed nearly 13 times.

Key takeaways

  • Category: Stocks.

Why it matters

A routine update. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at CNBC-TV18.

More Stocks news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.